Patheon Inc. announces final court approval of arrangement

          Patheon Inc. announces final court approval of arrangement  PR Newswire  TORONTO, March 10, 2014  TORONTO, March 10,  2014 /PRNewswire/  - Patheon Inc.  (TSX: PTI)  ("Patheon")  announced today that the Ontario  Superior Court of Justice (Commercial  List)  (the  "Court")  has  issued  a  final  order  approving  Patheon's  previously  announced statutory plan of arrangement  (the "Arrangement") under the  Canada  Business Corporations  Act  ("CBCA")   pursuant  to  which  JLL/Delta  Patheon  Holdings, L.P. ("Newco"),  which is sponsored  by an entity  controlled by  an  affiliate of  JLL Partners  Inc.  and Koninklijke  DSM N.V.,  will  indirectly  acquire all of the issued and outstanding restricted voting shares of Patheon. In issuing the final order, the  Court has determined that the Arrangement  is  fair and reasonable in accordance with the requirements of the CBCA.  It is expected that  the Arrangement will be  completed on Tuesday, March  11,  2014, assuming the satisfaction or waiver of certain customary conditions.  About Patheon Inc.  Patheon Inc.is  a leading  provider of  contract development  and  commercial  manufacturing services to the global pharmaceutical industry for a full  array  of solid and sterile  dosage forms. Through  the company's recent  acquisition  ofBanner Pharmacaps - a  market leader in soft  gelatin capsule technology  -  Patheonnow also includes a proprietary products and technology business.  Patheonprovides the highest  quality products and  services to  approximately  300 of the  world's leading  pharmaceutical and  biotechnology companies.  The  company's integrated network consists of 15 locations, including 12 commercial contract manufacturing  facilities  and  9  development  centers  acrossNorth  AmericaandEurope.Patheonenables customer  products  to  be  launched  with  confidence anywhere in the world. For more information visitwww.patheon.com.  Forward-Looking Statements  This press release contains "forward-looking information" or  "forward-looking  statements"  within  the  meaning  of  applicable  Canadian  securities  laws,  including statements regarding the proposed transaction and expected timing of the transaction,  which  forward-looking statements  may  use  forward-looking  terminology  such  as  "may",   "will",  "expect",  "anticipate",   "believe",  "continue", "potential", or the negative  thereof or other variations  thereof  or  comparable  terminology.  Such  forward-looking  statements  may  include,  without limitation,  statements  regarding  the  completion  of  the  proposed  transaction and other statements that are not historical facts.  These forward-looking  statements reflect  beliefs and  assumptions which  are  based on  Patheon's  perception  of current  conditions  and  expected  future  developments, as well as other factors management believes are appropriate  in  the  circumstances.  Patheon's  beliefs  and  assumptions  may  prove  to   be  inaccurate and consequently Patheon's  actual results could differ  materially  from the expectations set out herein.  While such forward-looking statements are  expressed by Patheon in good  faith  and believed  by Patheon  to have  a  reasonable basis,  they are  subject  to  important risks  and uncertainties  including, without  limitation, risks  and  uncertainties relating  to  the transaction  and  financing thereof,  and  the  satisfaction or  waiver  of  certain  other  conditions  contemplated  by  the  arrangement agreement dated November 18, 2013 between Patheon and Newco. As  a  result of these  risks and  uncertainties, the proposed  transaction could  be  modified, restructured or  may not  be completed,  and the  results or  events  predicted in  these  forward-looking  statements may  differ  materially  from  actual results or events. These forward-looking statements are not  guarantees  of future  performance,  given  that they  involve  risks  and  uncertainties.  Patheon is not affirming or adopting  any statements made by any other  person  in respect of the proposed  transaction and expressly disclaims any  intention  or obligation to update or revise any forward-looking statements, whether as a result of new information,  future events or  otherwise, except in  accordance  with  applicable  securities  laws  or  to  comment  on  expectations  of,  or  statements made by any other person in respect of the proposed transaction.  Cautionary Statement  No stock exchange,  securities commission  or other  regulatory authority  has  approved or disapproved the information contained herein.  SOURCE Patheon Inc.  Contact:  Patheon Inc. Tel: (919) 226-3200 Email:investorrelations@patheon.com